UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy - Is it worthwhile?

Foster, GR; D'Souza, RFC; Main, J; Crossey, M; Rosenberg, W; Murray-Lyon, IM; Hayward, C; (2003) Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy - Is it worthwhile? In: HEPATOLOGY. (pp. 646A - 646A).

Full text not available from this repository.


Type:Proceedings paper
Title:Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy - Is it worthwhile?

Archive Staff Only: edit this record